01 3Pfizer Canada ULC
01 12393640
02 12448281
03 12469350
01 3TOFACITINIB CITRATE
01 3TABLET
01 12020-11-23
02 12022-05-29
03 12022-11-25
Patent Expiration Date : 2022-11-25
Date Granted : 2009-09-29
Brand Name : XELJANZ
Patent Number : 2469350
Filing Date : 2002-11-25
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-11-25
Date Granted : 2009-09-29
Patent Expiration Date : 2022-05-29
Date Granted : 2009-05-05
Brand Name : XELJANZ
Patent Number : 2448281
Filing Date : 2002-05-29
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-05-29
Date Granted : 2009-05-05
Patent Expiration Date : 2020-11-23
Date Granted : 2006-09-05
Brand Name : XELJANZ
Patent Number : 2393640
Filing Date : 2000-11-23
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2020-11-23
Date Granted : 2006-09-05
LOOKING FOR A SUPPLIER?
